CORC

浏览/检索结果: 共1条,第1-1条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
A phase 3 study of durvalumab with or without bevacizumab as adjuvant therapy in patients with hepatocellular carcinoma at high risk of recurrence after curative hepatic resection or ablation: EMERALD-2 会议论文
作者:  Knox, J.;  Cheng, A.;  Cleary, S.;  Galle, P.;  Kokudo, N.
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace